China Vanke (2202) Announces Board Resolutions and Third-Quarter Impairment Details

Bulletin Express

Oct 30

China Vanke Co., Ltd. (Stock Code: 2202) convened the twenty-sixth meeting of its twentieth session of the board of directors on 30 October 2025, where nine directors participated. The meeting was deemed to have met all relevant regulatory and procedural requirements.

The board approved the 2025 Third Quarterly Report and Financial Statements, disclosing that China Vanke recognized or added RMB9,367.9452 million in impairment provisions in the third quarter of 2025, predominantly from new provisions for inventory impairment totaling RMB9,192.5974 million. During the same period, RMB1,708.2637 million of existing provisions were reversed or written off.

As of 30 September 2025, total impairment provisions stood at RMB53,914.8913 million, marking a rise of RMB7,659.6815 million compared to the end of the interim period of 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1153339939"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1153339939\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1153339939?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 23:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153339939","market":"us","top_or_hot":-1,"title":"China Vanke (2202) Announces Board Resolutions and Third-Quarter Impairment Details","media":"Bulletin Express","content":"<p>China Vanke Co., Ltd. (Stock Code: 2202) convened the twenty-sixth meeting of its twentieth session of the board of directors on 30 October 2025, where nine directors participated. The meeting was deemed to have met all relevant regulatory and procedural requirements.</p>\n<p>The board approved the 2025 Third Quarterly Report and Financial Statements, disclosing that China Vanke recognized or added RMB9,367.9452 million in impairment provisions in the third quarter of 2025, predominantly from new provisions for inventory impairment totaling RMB9,192.5974 million. During the same period, RMB1,708.2637 million of existing provisions were reversed or written off.</p>\n<p>As of 30 September 2025, total impairment provisions stood at RMB53,914.8913 million, marking a rise of RMB7,659.6815 million compared to the end of the interim period of 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>China Vanke (2202) Announces Board Resolutions and Third-Quarter Impairment Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChina Vanke (2202) Announces Board Resolutions and Third-Quarter Impairment Details\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-30 23:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Vanke Co., Ltd. (Stock Code: 2202) convened the twenty-sixth meeting of its twentieth session of the board of directors on 30 October 2025, where nine directors participated. The meeting was deemed to have met all relevant regulatory and procedural requirements.</p>\n<p>The board approved the 2025 Third Quarterly Report and Financial Statements, disclosing that China Vanke recognized or added RMB9,367.9452 million in impairment provisions in the third quarter of 2025, predominantly from new provisions for inventory impairment totaling RMB9,192.5974 million. During the same period, RMB1,708.2637 million of existing provisions were reversed or written off.</p>\n<p>As of 30 September 2025, total impairment provisions stood at RMB53,914.8913 million, marking a rise of RMB7,659.6815 million compared to the end of the interim period of 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02202","symbol_name":"万科企业","start_time":0,"source_url":"","article_id":"1153339939","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153339939","pubTimestamp":1761838432,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"China Vanke Co., Ltd. (Stock Code: 2202) convened the twenty-sixth meeting of its twentieth session of the board of directors on 30 October 2025, where nine directors participated. The meeting was...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02202":"万科企业"},"translate_title":"万科(2202)公布董事会决议及第三季度减值详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02202":1},"content_text":"China Vanke Co., Ltd. (Stock Code: 2202) convened the twenty-sixth meeting of its twentieth session of the board of directors on 30 October 2025, where nine directors participated. The meeting was deemed to have met all relevant regulatory and procedural requirements.\nThe board approved the 2025 Third Quarterly Report and Financial Statements, disclosing that China Vanke recognized or added RMB9,367.9452 million in impairment provisions in the third quarter of 2025, predominantly from new provisions for inventory impairment totaling RMB9,192.5974 million. During the same period, RMB1,708.2637 million of existing provisions were reversed or written off.\nAs of 30 September 2025, total impairment provisions stood at RMB53,914.8913 million, marking a rise of RMB7,659.6815 million compared to the end of the interim period of 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}